Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting

详细信息    查看全文

• 作者：Adel M. ElSohly ; Chawita Netirojjanakul ; Ioana L. Aanei ; Astraea Jager ; Sean C. Bendall ; Michelle E. Farkas ; Garry P. Nolan ; Matthew B. Francis
• 刊名：Bioconjugate Chemistry
• 出版年：2015
• 出版时间：August 19, 2015
• 年：2015
• 卷：26
• 期：8
• 页码：1590-1596
• 全文大小：390K
• ISSN：1520-4812

文摘

The present study describes an efficient and reliable method for the preparation of MS2 viral capsids that are synthetically modified with antibodies using a rapid oxidative coupling strategy. The overall protocol delivers conjugates in high yields and recoveries, requires a minimal excess of antibody to achieve modification of more than 95% of capsids, and can be completed in a short period of time. Antibody鈥揷apsid conjugates targeting extracellular receptors on human breast cancer cell lines were prepared and characterized. Notably, conjugation to the capsid did not significantly perturb the binding of the antibodies, as indicated by binding affinities similar to those obtained for the parent antibodies. An array of conjugates was synthesized with various reporters on the interior surface of the capsids to be used in cell studies, including fluorescence-based flow cytometry, confocal microscopy, and mass cytometry. The results of these studies lay the foundation for further exploration of these constructs in the context of clinically relevant applications, including drug delivery and in vivo diagnostics.